Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy

被引:50
作者
Rizzi, Elen [1 ]
Ceron, Carla S. [1 ]
Guimaraes, Danielle A. [1 ]
Prado, Cibele M. [2 ]
Rossi, Marcos A. [2 ]
Gerlach, Raquel F. [3 ]
Tanus-Santos, Jose E. [1 ]
机构
[1] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pharmacol, BR-14049900 Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pathol, BR-14049900 Ribeirao Preto, SP, Brazil
[3] Univ Sao Paulo, Dent Sch Ribeirao Preto, Dept Morphol Estomatol & Physiol, BR-14049900 Ribeirao Preto, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Matrix metalloproteinases; Cardiac hypertrophy; Renovascular hypertension; Reactive oxygen species; LEFT-VENTRICULAR HYPERTROPHY; ANGIOTENSIN-II; PRESSURE-OVERLOAD; TISSUE INHIBITOR; HEART-FAILURE; FAILING HEART; ACTIVATION; RATS; FIBROSIS; PEROXYNITRITE;
D O I
10.1016/j.yexmp.2012.10.010
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Cardiovascular remodeling found in later phases of two-kidney, one-clip (2K1C) hypertension may involve key mechanisms particularly including MMP-2, oxidative stress, transforming growth factor-beta (TGF-beta), and inactivation of the endogenous MMP inhibitor, the tissue inhibitor of MMP (TIMP)-4. We examined whether temporal cardiac remodeling resulting from 2K1C hypertension occurs concomitantly with alterations in cardiac collagen, MMP activity, MMP-2, TIMP-4, TGF-beta, and reactive oxygen species (ROS) levels during the development of 2K1C hypertension. Sham-operated and 2K 1C hypertensive rats were studied after 15, 30, and 75 days of hypertension. Systolic blood pressure was monitored weekly. Left ventricle (LV) morphometry and fibrosis were evaluated in hematoxylin/eosin and picrosirius red-stained sections, respectively. Cardiac MMP-2 levels/activity was determined by gelatin zymography, immunofluorescence, and in situ zymography. TIMP-4 levels were determined by western blotting. Cardiac TGF-beta levels were evaluated by immunofluorescence and ROS levels were evaluated with a dihydroethidium probe. 2K1C hypertension induced LV hypertrophy associated with augmented gelatinolytic activity at an early phase of hypertension and further increased after 75 days of hypertension. These alterations were associated with increased cardiac MMP-2, TGF-beta, and ROS in hypertensive rats. Higher TIMP-4 levels were found in hypertensive rats only after 75 days after surgery. Our findings show that increased MMP-2 activity is associated with concomitant development of LV hypertrophy and increased TGF-beta and ROS levels. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 44 条
[1]   ANGIOTENSIN-II STIMULATION OF PROTEIN-SYNTHESIS AND CELL-GROWTH IN CHICK HEART-CELLS [J].
BAKER, KM ;
ACETO, JF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (02) :H610-H618
[2]   Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction [J].
Bergman, Marina R. ;
Teerlink, John R. ;
Mahimkar, Rajeev ;
Li, Luyi ;
Zhu, Bo-Qing ;
Nguyen, Anita ;
Dahi, Sia ;
Karliner, Joel S. ;
Lovett, David H. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 292 (04) :H1847-H1860
[3]   ECM remodeling in hypertensive heart disease [J].
Berk, Bradford C. ;
Fujiwara, Keigi ;
Lehoux, Stephanie .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (03) :568-575
[4]   Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP4) to the COOH-terminal hemopexin-like domain of human gelatinase A - TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2 [J].
Bigg, HF ;
Shi, YE ;
Liu, YLE ;
Steffensen, B ;
Overall, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (24) :15496-15500
[5]   Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertension [J].
Buzello, M ;
Boehm, C ;
Orth, S ;
Fischer, B ;
Ehmke, H ;
Ritz, E ;
Mall, G ;
Amann, K .
VIRCHOWS ARCHIV, 2003, 442 (04) :364-371
[6]   Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats [J].
Castro, Michele A. ;
Rizzi, Elen ;
Figueiredo-Lopes, Livia ;
Fernandes, Karla ;
Bendhack, Lusiane A. ;
Pitol, Dimitrius Leonardo ;
Gerlach, Raquel E. ;
Tanus-Santos, Jose E. .
ATHEROSCLEROSIS, 2008, 198 (02) :320-331
[7]   Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling [J].
Castro, Michele M. ;
Rizzi, Elen ;
Prado, Cibele M. ;
Rossi, Marcos A. ;
Tanus-Santos, Jose E. ;
Gerlach, Raquel Fernanda .
MATRIX BIOLOGY, 2010, 29 (03) :194-201
[8]   Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension [J].
Castro, Michele M. ;
Rizzi, Elen ;
Rodrigues, Gerson J. ;
Ceron, Carla S. ;
Bendhack, Lusiane M. ;
Gerlach, Raquel F. ;
Tanus-Santos, Jose E. .
FREE RADICAL BIOLOGY AND MEDICINE, 2009, 46 (09) :1298-1307
[9]   The regulation of matrix metalloproteinases and their inhibitors [J].
Clark, Ian A. ;
Swingler, Tracey E. ;
Sampieri, Clara L. ;
Edwards, Dylan R. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (6-7) :1362-1378
[10]   Rat models of hypertension, cardiac hypertrophy and failure [J].
Doggrell, SA ;
Brown, L .
CARDIOVASCULAR RESEARCH, 1998, 39 (01) :89-105